Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hay wagon.. ooops buckboard..
Compared to many other Bio CEO's.. PH doesn't care about shareholders. He has a CFO to bring in funding as required.
Only the BoD, can cause a change in behavior and as mostly scientists, they are a different breed.
Glad we are airing out a bit of laundry.
Buck board, I agree and there is nothing for months to come on the horizen.. No milestones forecasted, no journals, just mind splitting silence. Never seen anything like this.
Yep.. Dow up big time this morning and MRKR down 6%.. this after last weeks Annual meeting and thus week ASCO. Share price not heading to $5 or $10 where it could be.. but I don't think management has " the goods." They can stay employed and compensated for years into the future with little transparancy, and having reverse stock splits and new share issuance.
Not interested in free wheeling philanthropy, but as an investment : dead money and a slow downward trend.
You may not like it, but posted with honesty.
Fuzzy memories... what a hoot..
... I thought he company would have ( still possible) released a summary for public consumption...
As I have said.numerpus times before, every one would like to see this company succeed.... I fear others might be better run and eat our lunch. I would feel much better with a share price above $10.00 thus allowing a great field of investors to buy in..not so below $5.00.. and not increasing at all until regular P/R's and transparency.. they have much to honestly share about the science, past and future,the industry, and management options. You can't argue this although on this board..any real question asking is viewed as " heresy."
Keep up the good research and open thinking and... your investment stance.
Gatta.... get it..before I die..
The meeting was this morning @ 8:00 AM CDST... My questions were not given..
Good for the volume and slight price increase... will it hold, increase over coming days, or revert back to declining.
We'll wait and see if any press release comes forth.. I had planned to be there in Houston attending, but this Virus prohibited that from taking place.
I don't have investment "hope "... I'd rather read transparancy and milestones..
The board was elected... salaries incrrased.. but.... a few here will offer thoughts and opinions.. GLTA..
Hanscott great work with investigation and reporting, good for you and good for us.
Today is the virtual Annual meeting. I can only hope that many " investor questions" will be asked and answered.
It's time to ask about better transoarancy and communications, future milestones, seeking partnerships or mergers or a sale if the company to a well funded and capable company.
Yes, I am jaded, having been through 2 reverse splits, continual SP decline, and a realization that MRKR has too talent whi get very well compensated regardless of results month to month, or year to year. I realize that they can R/S, dilute shareholders at will far into the future.
But, calmly today, I hope there will be important investment questions asked. I'll bet my two questions will never see the light of day today. I do fear a continuing decline in price and a few board insults. But, as one should say.. GLTA.
At 2:20 PM..the DOW is up 900 points.. then there is MRKR even with the Annual meeting this week... a big, big + .02..
Are they kidding?
What is your reading of investor both retail and houses of the results presented in the last 30 or so days?
The 2019 Annual report, the first quarter report, and now ASCO... it seems that little to no interest exists to move share price in an upward direction, rather a continued downward slope. Next weeks virtual Shareholder meeting is the last opportunity to shine for months to come.
Even though no one likes to think about it, the company says with ample disclaimers, the earliest therapies are 5 years out ( p.45).. they suggested that both TPIV 5 years ago.
My only question for the meeting is: have you received and interest in partnership and/ or buyout offer; or, are you seriously considering that option?
Micro.. yes, the boat we are adrift in has a few more seats and to far from land to swim... we can only hope for a kind lasting favorable wind.
Anti.. the science results will cause me to believe. I have hope for the antigen mix and I have awaited other results for the past 5 years. Who wouldn't want cures for some cancers? But, I need data that this company has what it takes.. in the science lab, in clinical studies, and in transparent communications.
Is that to much to ask? Apparently for some, it is.. but, I will honestly add GLTA.
Another SSDD..1 million more in cash burn.can't secure needed reagent, FDA hold remains, CV19 halted clinic work and trials, and we have little to hold on to.
To bad the CFO wouldn't significantly cut expenses.
I am now again accustomed to an underperforming company, under promising and delivering even less.
After hours drop was like a dog releiving itself on my leg... not surprised.
Today is " show and tell" day.I hope it will be more interesting than the kid who brings his teddy bear and talks about its missing eye.
Close: $2.40... I was hoping for $4.00 going into Monday's Q reporting ...
This is an unimaginable low micro market cap.
Pad... mine came also.. voted and sent within 20 minutes.. thank you..
Volume and price increase is most welcomed
but where this goes.. no one knows.. and widely varying opinions abound. Who are all these new posters??
What's the angle?
No, I did not see a MRKR pr this morning.
From others, I knew the date. But as stated have not received voting materials. Have you?
I'm NOT complaining, but I ask for compliance with U & C best practices, which I think is always reasonable.
From the " show me" state.. Peter and crew should have already read the Orphan drug status, seen a need for clarification and issued a press release.
Most of the exec group come across to me as the old " maytag repair man" phones disconnected, no calls, no action.
Wrong action. A clarification is needed by the marketplace whether great, good, or not good news. With the exception of the " booster club", most would agree that communication at best is terrible.
OT, I have not yet received Annual Meeting materials and voting instructions..( TDA, DAIN) Have all of you?
.....and wouldn't that be most welcomed.
We can hope. I have someone close to me with CML that is horrible, but if this OD for AML is successful... I feel so much for the patients returning to life health.
Hope is ours... science is Markers.
First, thank you for completeness which has little to do with DD..
Good fortune to you and all.
When an activity is important, the company is required to issue a press release and filing.
Short of that requirement, please, every poster with comments, post with complete sentences,leaving out any ambiguities... thanks..
Micro, I think that you are correct
.This is a weak managed company that has at its core " spend and hope, but don't report."
Other bios are advancing quicker with womens breast, cervical, and ovarian cancers. The Marker brand is not updated.
Look at the research and FDA support over CV-19 and ask... who are we and what really are we doing? I suggest finding a partner or selling out for the recovery of the shareholders. To me, not doing so is a matter of personal power while being highly compensated.
Thank you... I have 70,000 shares at an average of.$8.53.
I have not received a notice of the annual meeting as of today..
It sure seems that the items for voting are of self interest and aggrandizement.
I'd rather see progress and projection as a basis for their proposals.
Of course I would.judt like breakig even and heading for an exit after all these years and reverse splits.
This board is either seriously ill or has died. The science posters left more than a year ago. The investigators of company responses or a lack of left six+ months ago. No one was interested in technical trades and no one could get fundamentals of or from the company.
Peter may enjoy his colleagues mutual admiration, but retail shareholders disdain his lack of reasonable communications. The company shrouds itself in silence. Perhaps the word " shroud" is more than a descriptive word.. very disappointed in management, no power to change with votes because of no annual meeting, virtual or other.
Any thoughts on Seattle Genetics..FDA approval of HER2 + breast cancer drug Tukysa? Did they come first and left TPIV clinical studies "in the dust?"
Secondly, were we expecting updates in April?
Thirdly, what do we know of any advances in the last six + months? A lack of communication usually does not bode well for what ever successes may be.
Until MRKR releases data, causing a renewed focus on elements of the company, it seems that I hub board minds are idle and offer not much of value..
A small focus suggested.. look at the daily volume for the past five sessions.. I doubt any of it is on the " blood analysis" corporate reporting error. MRKR, inc. has nothing to do with it and I doubt it impacted traders. Did it for any of you?
Rather, I think think someone then someone's heard some potentially good developing results, not from MRKR, and they bought. Then algorithmic trading took over for a few hours.. volume/ price... upcoming decreased volume if it happens, will either range bind S/P or decline.
Yet.... in the coming months of this year, data will be forthcoming and share price will either boom or bust.. I'm no genius.
Really?.
At the minimum, there is a registered corporate name infringenant. In the earliest press release, didn't the FDA include as an address... Houston, Tx.?
IMO,it has been a long time since anything of MRKR updates. I know that P.H. has little interest in communications. But, do any of you read other bios and their communication efforts? Example, FATE, progress in Car-T.. even though we are TAP science...
IMO, MRKR has gone nowhere in over a year other than S/P decline.. not even releasing a Annual S/H planned meeting and or date deferral.. I have my overnight bag packed and sitting by the door.
Lastly, stay safe, and if you are, maybe post that you have thoughts.
On the Yahoo finance board, researcher."Pablo" states a new TPIV 100 research paper on the Her11 results was released and those are fabulous.
I wish P.H. would have the PR done for all shareholders.
SEC 10K 120 day limit on filing coming soon..March 30..
This weeks IR release is not the same as required.
Also, with AML and PC ... has the company not filed for a Fast Track opinion?
Lastly, is it really reasonable for us that the long time respected posters continue to remain behind wide tree trunks of the Bio forest?
So needed... also if we could be successful with AML/MDS... and breast and ovarian cancers..
..... if only it would happen.
... if only we were better communicated with.
Micro... on a macro basis, you are correct.
But, on a micro basis, there are sellers of MRKR... in daily up closings and down closings.
Everyone knows that management need to make things happen.. press releases.. stating when the annual financials and shareholder meeting will take place.. March 15 is nearly here.
Pipeline trials are so very important.
AML & MDS.. if only could get on a Fast Track FDA status.. so needed..
Breast and ovarian cancer...so needed to be proven efficacious. Even Polystart.. what can it be useful?
What we need are corporate updates.
That the Aspire short term financing has been accomplished is a real positive.
What will it take to have a S/P at $15?
IC.. I was amazed at the terms, including MRKR retaining complete control. Like you and others, this needs to be out under the the financing ' microscope'.. first blush suggests both parties believe that great results are on the horizon.
Thoughts by any or all of you?
Not yet seen the 8K.
If great events do come, nothing would please me more than to retract my negative posts of past years, and praise management at the Annual Shareholders meeting.
" For whatever it means..".. it means a 1,032 Dow point drop hit every stock.. means nothing for MRKR just as the after session of +.26 means nothing
Of a fiscal year, the three quarters must be reported on or before 45 days from Q ending. The 4th quarter is the Annual reporting and has 90 days. Look to March 31 or earlier. The MD&A section should be loaded.
Meanwhile,there could be positive releases before including the 2 investor conferences ( never go with empty pockets) and the London presentation.
I will be at the shareholders meeting when listed.
I.C...it seems that not only are you and I in the same boat, but I may be sitting next to you.
As a business model, this stinks.
Marker's Fiscal Year ended December 31, 2019. Unlike prior TPIV years, this year had fewer Press Releases, fewer important presentations, a few botched presentations, an alarming share price decline, a need for partners and additional capital which was hoped for at a minimal dilution, but now looks devestating. The company hired numerous too rated professionals to what positive informative outcomes?
I await the announcement of the Annual Shareholder meeting date and location. I will be there to proclaim my support if we receive valuable updates, or if not determined to ask pointed questions as to the pipeline, why poor communications, and is the company for real or will competitors complete the real work.
If you wish to " rip" into my thoughts, meet me there and lets talk business, investment, and science.
Get lost.. find better things to chew on.. we're interested in the clinical trial updates and the business plan.
D.
Oh please... I've been around the track numerous times. DD includes many areas of information.. SEC filings. Corporate press releases, outside research, and posters.. some of whom are very valued.
My easy to understand post cited a reduction of each of the above items and a lessening of analytical support. So. Please give credit where do.
IC, and as a result of their enthusiasm and a CEO who used to communicate more and better, we became the " bag holders."
While we continue to experience an almost daily erosion of investment/ownership money from a year ago high ~ $9.00..
... it is more than reasonable for Peter to update from the last data on July 22, 2019, 6 months ago on the 3 arm PC trial. Arm A 9 pts..1 CR, over half surpassed the median survival rate.. where are we 6 months later? Arm B, of 6, 3 improved, 3 declined, and arm C data mixed.. where are we 6 months later.
Where are we with the FDA approval for trials expansion?
Mr. CFO. What is the strategy of increasing the share price before another reverse split and dilutive financing with crazy warrant pricing, as in the two previous events?
With a few exceptions, the rest of us
seem to agree that from a business stand point ( and this IS a business) communications are among the worst.
Lastly, once again, the posting board has turned over from the most frequent posters. This is the third time I have seen this. Who remembers RW and Blu.. who remembers PL and machisti and others?
If this medical schools ( Baylor and Mayo) research and testing is not being accepted or others are becoming more successful quicker, wouldn't you want to know?
I'd be so very honored to apologize if data surpassed my concerns.. of course, I have posted this for 6 months.